17β-Estradiol attenuates oxidative impai
✍
Jeffrey N. Keller; Ariane Germeyer; James G. Begley; Mark P. Mattson
📂
Article
📅
1997
🏛
John Wiley and Sons
🌐
English
⚖ 140 KB
Synapse loss, deposits of amyloid -peptide (A), impaired energy metabolism, and cognitive deficits are defining features of Alzheimer's disease (AD). Estrogen replacement therapy reduces the risk of developing AD in postmenopausal women. Because synapses are likely sites for initiation of neurodeg